Scinai Immunotherapeutics Ltd. raised capital through a Standby Equity Purchase Agreement on September 2, 2025.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Scinai Immunotherapeutics Ltd. raised capital through a Standby Equity Purchase Agreement on September 2, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Yorkville Advisors
New Jersey-based alternative investment manager
Nothing else this week.
Coverage
Newest first; wire copies grouped- PR NewswireScinai Reports Six-Month 2025 Financial Results Highlighting Continued CDMO Revenue Growth and Strengthened Balance Sheet JERUSALEM, Sept. 2, 2025 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASD